POPULARITY
7 episodes with Bacteriology
7 episodes with Bacteriology
5 episodes with Bacteriology
2 episodes with Bacteriology
2 episodes with Bacteriology
5 episodes with Bacteriology
2 episodes with Bacteriology
2 episodes with Bacteriology
2 episodes with Bacteriology
ReferencesArch. Biochem. Biophys. 335:102-108.J of Bacteriology. 2007. December 1, Volume 189 Issue 23Cell Death & Disease 2016 volume 7, page e2488Science Translational Medicine 2018. 30 May Vol. 10, Issue 443, eaan4116J Biol Chem. 2024 Oct 24;300(12):107920Bach, JS 1717-1723. Violin Concerti BMV 1041-1043https://open.spotify.com/album/4ORRtG6LetuodMPkvpBJIs?si=xMzOYCdtTpqwyi_v0xeJlQMiller, S. 1968. Children of the Future lp.https://open.spotify.com/album/2Mg8p4nAkfSzkYxUuRNTz8?si=B6rNhPddTGm9VIbu0ZL-Iw
Edward G. Dudley, Ph.D. is the Director of the E. coli Reference Center and a Professor of Food Science at the Pennsylvania State University. He has a broad background in molecular biology, physiology, and foodborne bacteria genomics, with expertise in both beneficial and pathogenic species. His current research program focuses on factors that drive the virulence of Escherichia coli O157:H7 and the development of DNA sequence-based methods for tracking pathogen spread during foodborne illness outbreaks, including wastewater monitoring. Dr. Dudley is a past Chair of the Food Microbiology Division of the American Society of Microbiology (ASM), the Food Microbiology Representative to ASM's Council of Microbial Sciences, and a previous member of ASM's Microbe Program Committee. In 2019, he was appointed an ASM Distinguished Lecturer and Co-Editor of the Evolution and Genomics domain for ASM's online journal, EcoSal Plus. He was also elected to the American Academy of Microbiology in 2023. Dr. Dudley holds a Ph.D. in Bacteriology and an M.S. degree in Food Science, both from the University of Wisconsin–Madison. In this episode of Food Safety Matters, we speak with Dr. Dudley [35:17] about: A study conducted by Dr. Dudley's lab that investigated the usefulness of wastewater monitoring for surveillance of foodborne Salmonella illnesses How whole genome sequencing (WGS) was used to link Salmonella isolates from wastewater systems in central Pennsylvania to an existing salmonellosis outbreak The significance of discovering the rare S. Baildon serotype in the wastewater samples How wastewater monitoring activities could fill gaps created when foodborne illnesses go underreported by infected people, as well as the potential limitations of wastewater monitoring for foodborne illness surveillance Other foodborne pathogens besides Salmonella that could be surveilled via wastewater monitoring Apart from the Salmonella wastewater monitoring study, various research projects carried out by Dr. Dudley's lab related to E. coli. Before we speak to Dr. Dudley, we also hear from Patrick Schneider [25:37], Vice President of Operations and Engineering (Chlorine Dioxide) at CDG Environmental LLC. In his interview, he discusses the usefulness of chlorine dioxide for food plant sanitation, and what makes CDG Solution 3000TM the “gold standard in chlorine dioxide solutions.” Prior to joining CDG Environmental, Mr. Schneider spent 35 years holding various global roles in the oil and gas industry. He holds a B.S. degree in Petroleum Engineering from Penn State University. News and Resources News FDA Delays FSMA 204 Traceability Rule Compliance Date by 30 Months [4:02]FDA Launches ‘Operation Stork Speed' to Improve Infant Formula Safety, Including Contaminant Testing [11:08]Thousands More Layoffs Coming to FDA, CDC as HHS Announces Major Restructuring [12:06]Microplastics Increase Antibiotic Resistance of E. coli, Aid Biofilm Formation, Study Shows [18:12]Proposed Rule Would Require Mandatory Labeling on Alcoholic Beverages for Big 9 Food Allergens [22:35]Trump Admin Nominates CDC Acting Director Dr. Susan Monarez as Agency's Next Director [23:10]Boar's Head Appoints Natalie Dyenson as Chief Food Safety Officer [24:09] Resources Get 20 percent off your 2025 Food Safety Summit registration with code “FSMatters20” Wastewater Monitoring Can Aid Foodborne Illness Surveillance, Study Shows Wastewater Surveillance Useful for Norovirus Outbreak Detection Presenting Sponsor: CDG Environmental Visit CDG Environmental at Booth #333 at the 2025 Food Safety Summit! We Want to Hear from You! Please send us your questions and suggestions to podcast@food-safety.com
Dr. Edward DeLong is a Professor in the Department of Oceanography at the University of Hawai'i Mānoa as well as a Visiting Professor in the Department of Civil and Environmental Engineering at MIT. Research in Ed's lab brings together a variety of disciplines to study microbial communities in the ocean. He is interested in their ecology, evolution, biochemistry, genomics, and their impacts on marine systems. Particularly of interest for Ed are the microscopic organisms that are the primary producers or “forests of the ocean” responsible for releasing oxygen and serving as food for other organisms in marine food chains. When he's not working, Ed loves to be out in nature. He enjoys spending time outside with his family, hiking, kayaking, and snorkeling in the beautiful coral reefs near his house. Ed has also taken up yoga to help him stay limber and relaxed. Ed received his B.S. in Bacteriology from the University of California, Davis and his Ph.D. in Marine Biology from the Scripps Institute of Oceanography. Afterwards, he conducted postdoctoral research at Indiana University. Ed has worked as a research scientist at the Woods Hole Oceanographic Institute, a faculty member at the University of California, Santa Barbara, a research scientist at the Monterey Bay Aquarium Research Institute, and a faculty member at MIT before accepting his current position in Hawai'i. His honors and achievements include the Office of Naval Research Young Investigator Award, the DuPont Young Faculty Award, the Apple Bioinformatics Cluster Award, the Vladimir Ivanovich Vernadsky Medal of the European Geosciences Union, the Proctor and Gamble Award in Applied and Environmental Microbiology, American Society for Microbiology D.C. White Research and Mentorship Award, the UC Davis College of Biological Sciences Outstanding Alumni Award, A.G. Huntsman Medal for Excellence in Marine Science, and the Moore Foundation Marine Microbiology Investigator Award. Ed is also an Elected Fellow of the American Academy of Arts and Sciences, the National Academy of Sciences, the American Association for the Advancement of Science, and the American Academy of Microbiology. Ed has also been elected as an Associate of the European Molecular Biology Organization and is the Vice President and President Elect of the International Society of Microbial Ecology. In addition, he currently serves as the co-director of the Simons Collaboration on Ocean Processes and Ecology (SCOPE). Ed joined us for a conversation about his experiences in life and science.
ETT MORDFÖRSÖK MED REFERENSER. David tar i från tårna och bjuckar på riktigt matiga shownotes! Vorlaufing, Oskar Bruno, Pat Heist och … i princip allt som går att läsa om jäsning. NERDGASM INCOMING. Här tipsas vi om en bok som David faktiskt inte har läst. Jo, det är sant! Åtminstone inte hela … Redbreast 12 mot Redbreast 12 cask strength: http://tjederswhisky.se/redbreast-12-pa-40-och-fatstyrka/ Vad var det i glaset? Mathias njöt av J. P. Wiser 42 YO: https://www.jpwisers.com/en-ca/blog/meet-jp-wisers-42-year-old-a-new-milestone-in-canadian-whisky-excellence/ Jeroen hade istället J. P. Wiser 23 YO: http://tjederswhisky.se/jp-wiser-23-yo-cask-strength-for-sweden/ David hade två whiskylikörer som han rekommenderar av hela sitt hjärta: https://www.systembolaget.se/produkt/sprit/shanky-s-whip-5417701/ https://www.systembolaget.se/produkt/sprit/skrewball-9343301/ Från ax till fylla: mer om mäskning, lite om vört, och så det där med jäsning… ”I'll never be your yeast of bourbon, feat. Dr. Pat Heist”, En trea whisky 28/9 2021: https://www.entreawhisky.se/78 Lautertunnor: https://www.entreawhisky.se/87 När Oskar Bruno pratade jäst i ETW: https://www.entreawhisky.se/208 Vorlaufing kan man läsa lite om här: https://beerandbrewing.com/the-art-and-the-science-of-the-vorlauf-process/ https://makebeereasy.com/vorlauf/ Det där med Lochlea och Laphroaig och John Campbell och röra runt lite mer i mäsktunnan tror David han pratade om här: https://whiskycast.com/a-million-miles-from-laphroaig-to-lochlea-episode-910-december-6-2021/ Med risk att mörda er med referenser och ge en inblick i hur sjuk Davids hjärna är: här följer en del men långt ifrån allt av vad David har läst bara om jäst och jäsning: Andrew G. H. Lea & John R. Piggott, red., Fermented beverage production, 2 uppl. (New York: Springer Science & Business Media, 2003). Gray, William D., ”Further studies on the alcohol tolerance of yeasts”, Journal of Bacteriology 42 (1941), s. 561–574. Gray, William D., ”Studies on the alcohol tolerance of yeasts”, Journal of Bacteriology 55 (1948), s. 53–59. [Luening, Horst], ”Fermentation”, odaterad text, https://www.whisky.com/information/knowledge/production/details/fermentation.html Noguchi, Y., K. Urasaki, H. Yomo & T. Yonezawa, ”Effect on new-make spirit character due to the performance of brewer's yeast – (II) various yeast strains containing commercial strains”, i Distilled spirits: Production, technology and innovation, red. James Huthison Bryce, John R. Piggott & George G. Stewart (Nottingham: Nottingham University Press, 2008), s. 117–122. Reid, Struan J., et al., ”The influence of yeast format and pitching rate on Scotch malt whisky fermentation kinetics and congeners”, Journal of the Institute of Brewing 129, no. 2 (2023), s. 1–17. Russell, Inge & Graham Stewart, ”Distilling yeast and fermentation”, i Russell, Inge & Graham Stewart, red., Whisky: Technology, production and marketing, 2 uppl. (Oxford: Academic Press, 2014), s. 123–146. Stewart, Graham G. & Stephen A. Martin, ”Wort clarity: Effects on fermentation”, Master Brewers Association of the Americas Technical Quarterly 41, nr. 1 (2004), s. 18–26. Strengell, Teemu, ”Fermentation flavours”, 23/11 2011: http://whiskyscience.blogspot.se/2011/11/fermentation-flavours.html van Beek, Sylvie & Fergus G. Priest, ”Evolution of the lactic acid bacterial community during malt whisky fermentation: a polyphasic study”, Applied and environmental microbiology 68, nr. 1 (2002), s. 297–305. Walker, Graeme M., James Brosnan, Thomas A. Bringhurst & Frances R. Jack, ”Selecting new distilling yeasts for improved fermentation and for sustainability”, i Distilled spirits: Science and sustainability: Proceedings of the Worldwide distilled spirits conference, red. Graeme M. Walker, I. Goodall, R. Fotheringham & D. Murray (Nottingham: Nottingham University Press, 2012), s. 127–136. Walker, J. W., S. Y. Pearson, T. A. Bringhurst & J. M. Brosnan, ”Towards improved distilling yeast: effect of wort gravity and pitching rate on fermentation performance”, i Distilled spirits: Production, technology and innovation, red. James Huthison Bryce, John R. Piggott & George G. Stewart (Nottingham: Nottingham University Press, 2008), s. 127–132. Waymark, Christopher & Annie E. Hill, ”The influence of yeast strain on whisky new make spirit aroma”, fermentation 7, nr. 4 (311), s. 1–11. Wilson, Nicolas, ”Contamination: bacteria and wild yeasts in a whisky fermentation”, i Russell & Stewart, red. (2014), s. 147–154. Yonewaza, T. & Graham G. Stewart, ”Monitoring and controlling of whisky fermentation”, i James Hutchison Bryce & Graham G. Stewart. red., Distilled spirits: Tradition and innovation (Nottingham: Nottingham University Press, 2004), s. 103–111. Det här är en till sådan där bok David har lovat sig själv att aldrig läsa hela men finns det någon stolle därute så varmt välkomna att ta tag i: Stewart, Graham G., Brewing and distilling yeasts (Cham: Springer, 2017). lag phase och log phase återkommer vi till! Men för den som vill få nerdgasm bara av hur många parametrar som kan ritas in i ett och samma diagram, kolla in denna skönhet: https://www.wolfers.se/wp-content/uploads/2025/03/jasning.png Källa: Inge Russell & Graham Stewart, ”Distilling yeast and fermentation”, i Russell & Stewart, red. (2014), s. 143. Med benäget tillstånd från författarna. Här når du oss: En trea whisky på Facebook (https://www.facebook.com/entreawhisky) Maila till oss på hej@entreawhisky.se Davids blogg tjederswhisky.se (https://www.tjederswhisky.se) Följ oss på Instagram: https://www.instagram.com/entreawhisky Bli medlem! https://entreawhisky.memberful.com/checkout?plan=74960
Photo: Irish Midland Ringing Group A study led by University of Galway has revealed that swans in the Greater Dublin and Co Kildare area frequently carry antimicrobial resistant (AMR) bacteria in their guts that are very similar to those that cause difficult-to-treat infections in humans. The findings, from the research project titled WILD-AMR, indicate that swans living in urban waterways can act as a reservoir for pathogenic, multidrug-resistant bacteria, including some that are resistant to last-resort antibiotics. University of Galway study shows high rates of antimicrobial resistant bacteria in swans AMR is one of the most pressing global health challenges as it affects human and animal health, agriculture, food systems, and the environment. Working with the Irish Midland Ringing Group, faecal samples from 17 swans living in several locations around the Greater Dublin Area, including Broadmeadow Estuary in Swords, Bray harbour, Newbridge, Co Kildare, and along the Grand Canal in Dublin city were collected for analysis. Of the 17 samples, 11 were positive for one or more AMR bacteria, with 35 AMR bacteria detected overall. The most common type of AMR bacteria detected were multidrug-resistant E. coli that produced enzymes capable of breaking down beta-lactam antibiotics (ESBL-E. coli). The WILD-AMR project adopted a One Health approach to tracking the spread of AMR pathogens, investigating the links between human, animal and environmental health. The research team explored whether wild animals living and feeding in human impacted habitats were potential vectors of AMR. Key findings include: A high prevalence of AMR was detected in swans, with 65% positive for one or more AMR "superbug" Resistance to last-resort antimicrobials: The team detected strains of E. coli resistant to the last-resort antibiotics carbapenems and colistin, which are reserved for use when the first and second-line antimicrobials fail to clear the infection "High-risk clones": whole genome sequencing revealed that over half of the multidrug-resistant E. coli carried by swans belonged to "high-risk clones"; closely related pathogenic E. coli that are very good at causing urinary tract and blood stream infections in humans. Lead researcher of the study Aneta Kovarova, Senior Technical Officer in the School of Medicine at University of Galway, said: "We detected the same pathogenic AMR E. coli in multiple swans, both from those living in the same location and those living in different locations. It is likely that the high rate of detection of these AMR bacteria in swans is linked to human-associated pollution of their shared water habitat with treated and untreated wastewaters and through storm water overflows. However direct spread from swan to swan cannot be ruled out." Principal Investigator Dr Liam Burke, Lecturer in Bacteriology in the School of Medicine at University of Galway, said: "Given their proximity to humans and their presence in many popular bathing and recreation locations, such as city parks, lakes, harbours and coastal areas, there is potential for ongoing spread of drug-resistant opportunistic pathogens in swan faeces. Overall, this research underscores the interconnectedness of environmental, animal and human health. Our findings suggest that swans may be an under-recognised vector of AMR bacteria. "There is currently very little surveillance of AMR in wildlife. We propose that swans may represent a useful "sentinel" wildlife species for One Health monitoring of AMR, as they are already monitored by ringing in many countries." The study, published in the Science of the Total Environment, is available here. The study was funded by the European Union's Erasmus+ Programme, the Environmental Protection Agency, and the Health Service Executive. About University of Galway Established in 1845, University of Galway is one of the top 2% of universities in the world. We are a bilingual university, comprised of four colleges, 18 schools and fi...
Dr Liam Burke, Lecturer in Bacteriology in the School of Medicine at University of Galway discusses the findings of a study which found worrying bacteria levels in swans very similiar to those that cause difficult to treat infections in humans.
Watch this episode uncensored & ad-free on Patreon: https://patreon.com/dannyjones Dr. Ammon Hillman earned his MS in Bacteriology and Ph.D. in Classics from the University of Wisconsin Madison, where he specialized in Ancient Greek and Roman medicine and pharmacy. Dr. Hillman was recently investigated by the Vatican for demon possession and portal opening while teaching as a professor of Classical Languages. He currently teaches ancient Greek on his @ladybabylon666 YouTube channel. SPONSORS https://truewerk.com/danny - Get 15% off your first order. https://shopify.com/dannyjones - Sign up for your $1 per month trial. https://buy.ver.so/danny - Get 15% off your first order. EPISODE LINKS Ammon's YouTube Channel: @ladybabylon666 The Chemical Muse: https://amzn.to/3V6hOwb FOLLOW DANNY JONES https://www.instagram.com/dannyjones https://twitter.com/jonesdanny OUTLINE 00:00 - Why no one will debate Ammon 13:25 - Christianity vs classical civilization 17:27 - The FIRST Christ 25:06 - the Rod of Hermes 28:31 - History of the word "Christ" 35:27 - Jesus' relationship with Mary 40:21 - Why are we so far behind the Greeks? 43:38 - Epic of Gilgamesh vs. Aristotle 48:31 - Is the Septuagint a Greek original? 01:04:14 - Using drugs to control ancient populations 01:07:05 - The Talmud 01:10:08 - Carl Ruck & Ammon's relationship 01:16:47 - Mary Magdalene's salvation 01:22:05 - Jesus encouraged people to use drugs 01:22:52 - Jesus was tripping during his crucifixion 01:32:50 - Nero's death inducers 01:40:40 - Caligula 01:51:02 - New Egyptian mug discovery 01:56:30 - Reverse engineering the Bible 02:07:02 - Truth about Plato 02:12:23 - Ammon responds to Wesley Huff 02:21:44 - Jesus at the park with a young boy 02:28:44 - How Ammon got fired from University of Wisconsin Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr Ziko Konwar is joined by Dr Christopher Hassall and Professor Ulf Andersson to discuss the intricate linkages between biodiversity and business strategies, with an emphasis on operations of multinational enterprises. As part of the conversation, they explore questions such as how can businesses co-create value when it comes to preserving biological resources and mitigating the pace of biodiversity loss. And what are some of the major challenges for multinational companies integrating nature-based solutions into their business models? This episode was recorded on 3rd October 2024. If you would like to get in touch regarding this episode, please contact research.lubs@leeds.ac.uk. A transcript of this episode is available. About the speakers: Dr Ziko Konwar is an Assistant Professor of International Business at Leeds University Business School, and is the Director of Internationalization for the International Business Department. His research interests are in global strategy of multinational enterprises, with an emphasis on cross-national institutional and systemic challenges. He is the Leeds University Business School Research Lead for the 24-26 Cheney Fellowship project (see below), University of Leeds. Dr Christopher Hassall is an Associate Professor of Animal Biology in the School of Biology at the University of Leeds. He co-directs the Leverhulme Extinction Studies Doctoral Training Programme and co-leads the Aeroecology Research Group, which focuses on using radar for biodiversity monitoring. His research interests span fundamental ecology and biodiversity conservation, with a particular emphasis on interdisciplinary solutions to biodiversity challenges. Professor Ulf Andersson is a Professor of Business Studies in Mälardalen University, Sweden. Ulf is a research leader and expert on subsidiary management strategy of multinational enterprises, and is a Fellow of the Academy of International Business and European International Business Academy. Ulf is the first Cheney Fellow to be hosted at Leeds University Business School, University of Leeds. About the project:The Cheney fellowship project will utilize inter-disciplinary research expertise to address the role of global strategy of multinational enterprises (MNEs) in biodiversity loss (e.g. species/habitat extinction and MNE global innovation). The research team comprises Professor Ulf Andersson (incoming Cheney Fellow), Dr Ziko Konwar, Professor Yingqi (Annie) Wei and Professor Frank McDonald (Leeds University Business School), Dr Christopher Hassall (Faculty of Biological Sciences,) and Professor George Holmes (School of Earth and Environment). Over the past ten years, the Cheney Fellowship programme has established fruitful and high-impact research partnerships in areas such as water security, molecular biology, medicine and materials science. This programme has been made possible through a $4 million gift from Bacteriology and Biochemistry graduate Peter Cheney and his wife Susan.
In one of the strangest episodes to date, Dr. D.C.A. Hillman explains the ancient ingredients in the Theriac and the practice of using children as drugs.D. C. A. Hillman earned his Ph.D./M.A. in Classics and M.S. in Bacteriology from the University of WisconsinKykeon Analytics A fully anonymous mail-in drug checking lab service. CannaclearGet 15% off with the code HamiltonLucy Tobacco Free NicotineLucy's mission is to reduce tobacco-related harm to zero.Matcha.comAndrew Weil MD's matcha tea company. Use the code "Hamilton" for up to 20% off + a FREE gift.New BrewA delicious, euphoric seltzer.Top Tree Herbs Kratom Tea BagsTop Tree Herbs is the first kratom tea bag companySynergetic Press Use the code: the-hamilton-morris-podcast20 to get 20% off any book, including PiHKAL and TiHKAL!Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the show
Watch this episode uncensored & ad-free on Patreon: https://patreon.com/dannyjones Dr. Ammon Hillman earned his MS in Bacteriology and Ph.D. in Classics from the University of Wisconsin Madison, where he specialized in Ancient Greek and Roman medicine and pharmacy. His first book, The Chemical Muse, was published with St. Martin's Press immediately after his dissertation committee forced him to delete all references to recreational drugs from his thesis. Dr. Hillman was recently investigated by the Vatican for demon possession and portal opening while teaching as a professor of Classical Languages. SPONSORS https://mudwtr.com/danny - Try it now for only $29. (that's less than $1 per cup) https://buy.ver.so/danny - Use code DANNY to save 15% on your first order. https://whiterabbitenergy.com/?ref=DJP - Use code DJP for 20% off EPISODE LINKS Ammon's YouTube Channel: @ladybabylon666 The Chemical Muse: https://amzn.to/3V6hOwb FOLLOW DANNY JONES https://www.instagram.com/dannyjones https://twitter.com/jonesdanny OUTLINE: 00:00 - Religious history 11:24 - Tal Megiddo excavation 16:39 - Original meaning of "Christ" 17:51 - Neuro Peptides 23:25 - Ancient pharmacology; John Scarborough 28:23 - Galen (Marcus Aurelius doctor) 33:44 - Drugs in ancient Rome 38:02 - Chemical Muse 47:11 - Greek Septuagint VS Dead Sea Scrolls 55:57 - Greek drug cults 01:03:08 - Solon & the creation of democracy 01:10:21 - The ancient Bible 01:16:40 - Greek came before Hebrew 01:19:08 - Interpreting ancient texts 01:24:15 - John Marco Allegro 01:28:39 - Why the Greek language is superior 01:33:59 - The "Purple" 01:38:23 - Christian Cults & Revisionism 01:46:49 - The Christ 01:55:52 - Zeus 02:05:59 - The Garden of Gethsemane 02:16:46 - The 'Burning Purple' 02:27:52 - Death of Jesus 02:41:31 - Using the human body to produce drugs 02:43:58 - The men crucified next to Jesus 02:52:08 - Demon possession & opening portals 03:02:03 - Alexander The False Prophet 03:08:46 - Lucifer: the dawn bringer 03:17:38 - Modern Enlightenment
PEG Podcast With Dr. Cindy Starke: How to Tap Into Unshakeable Confidence Biography As an accomplished, driven, passionate, engaging, and energetic pioneer woman, she encourages audiences to get honest with their food, activity, and sleep choices, mindset, relationships, and spirituality to challenge their preconceived notions of what they are capable of, and unleash and discover the champion that has always been inside of them. As an award-winning author, doctor, entrepreneur, and mentor, Dr. Cindy Starke has inspired a hundred thousand patients across America to be the best versions of themselves. Dr. Starke was the first person in her family to attend college, but she didn't stop with her bachelor's degree. She challenged herself and was awarded the prestigious Woodruff Scholarship at Emory University, and received both an MD and a PhD in Molecular Genetics. As a board certified internal medicine physician for over 20 years, she has cared for patients in every setting possible, from urgent care and traditional outpatient clinics to the hospital. She has appeared on radio shows and a dozen podcasts and has been profiled in Moxie magazine and Gainesville Times Newspaper in the Northeast Georgia region. Her genetic research has been published in peer reviewed national scientific journals including Journal of Bacteriology and Journal of Infectious Diseases. Her signature style of delivery - passionate, energetic, and brutally honest - has set her apart as a speaker, teacher, and trainer. She is the award-winning author of “From Fear and Failure to the Finish Line- Unleash Your Potential and Discover the Champion Within” in which she chronicles her circuitous journey to the finish line of an Ironman Triathlon - 140.6 miles of ocean swimming, biking, and running. Through her group and individual mentoring programs, she is dedicated to helping women entering the second half of their lives identify what is preventing them from having ideal health and longevity, to embrace their power, challenge their self limiting beliefs, and use the power within to completely change the trajectory of their lives going forward. Link: http://drcindystarke.com/spark-call Donate to support PEG free artist interviews: PayPalMe link Any contribution is appreciated: https://www.paypal.com/paypalme/PhantomElectric?locale.x=en_US Support PEG by checking out our Sponsors: Download and use Newsly for free now from www.newsly.me or from the link in the description, and use promo code “GHOST” and receive a 1-month free premium subscription. The best tool for getting podcast guests: Podmatch.com https://podmatch.com/signup/phantomelectricghost Subscribe to our Instagram for exclusive content: https://www.instagram.com/expansive_sound_experiments/ Donate to support PEG free artist interviews: Subscribe to our YouTube https://youtube.com/@phantomelectricghost?si=rEyT56WQvDsAoRpr PEG uses StreamYard.com for our live podcasts https://streamyard.com/pal/c/6290085463457792 Get $10.00 Credit for using StreamYard.com when you sign up with our link RSS https://anchor.fm/s/3b31908/podcast/rss --- Send in a voice message: https://podcasters.spotify.com/pod/show/phantom-electric/message
Dr. Eric Skaar is Director of the Institute for Infection, Immunology and Inflammation, Director of the Division of Molecular Pathogenesis, the Ernest W. Goodpasture Chair in Pathology, and Vice Chair for Research and a University Distinguished Professor in the Department of Pathology, Microbiology, and Immunology at Vanderbilt University. Eric is a bacteriologist who studies the impact of nutrition on infectious disease. His research examines how the food we eat affects our susceptibility to bacterial infection and how the bacteria that infect us get food once they are inside our bodies. He earned his B.S. in Bacteriology from the University of Wisconsin-Madison, his Ph.D. in Immunology and Microbial Pathogenesis from Northwestern University, and his M.P.H. in Epidemiology and Biostatistics from Northwestern University. Afterwards, he completed a postdoctoral fellowship in microbiology at the University of Chicago before joining the faculty at Vanderbilt in 2005. Eric has received numerous awards and honors for his research including being named an American Asthma Foundation Scholar, receipt of Vanderbilt University's Stanley Cohen Award for Excellence in Research Bridging Disciplines, the Pfizer ASPIRE Young Investigator Award, the Vanderbilt Chancellor's Award for Research, and more. He has also won a variety of awards for exceptional mentorship and teaching, including the Vanderbilt Molecular Pathology and Immunology Graduate Program Teacher of the Year Award, the F. Peter Guengerich, Ph.D., Award, the Vanderbilt University Medical Center Postdoc Mentor of the Year Award, and others. In addition, he is an elected Fellow of the American Association for the Advancement of Science and the American Academy of Microbiology. In our interview, Eric shares more about his life and science.
Liz Lee Heinecke is an author and media figure for science and STEM. She has loved science she was young which drew her to study molecular biology where she worked in research for ten years. As she transitioned to parenting, she began sharing her love of science through experiments with her kids which became the basis for her books and media appearances. She has a Bachelor's Degree in Art and a Master's Degree in Bacteriology.What do we talk about in this episode?How Liz got involved in writing and media appearances in STEM.How you can potentially get involved in presenting STEM on TV.Her philosophy about saying "yes" and trying anything which has led to great experiences.Teachers can put kids on a good or bad trajectory. They have a lot of influence - good or bad.Math is a language and should be taught as a language.Experiment Outside the Box.Music used in the podcast: Higher Up, Silverman Sound StudioYou can support my podcast on Patreon here: https://patreon.com/user?u=72701887ResourcesLiz's website with her books and appearances: www.lizleeheincke.comConnect with Liz here: Email at lizleeheinecke@gmail.com or find her @lizheinecke on Instagram, @kitchpantrysci on Twitter and Liz Heinecke, The Kitchen Pantry Scientist on Facebook.Books:Biology for KidsKitchen Science Lab for Kids, Edible EditionOutdoor Science Lab for KidsChemistry for KidsSTEAM Lab for KidsKitchen Science Lab for KidsStar Wars The Padman CookbookEcology for KidsPhysics for KidsStar Wars Maker LabSheet Pan ScienceKitchen Science for KidsShe Can STEM: 50 Trailblazing Women in Science From Ancient History to NowSuper Fun Kitchen Science Experiments for Kids: 52 Family Friendly Experiments From Around the WorldRadiant: The Dancer, The Scientist, and a Friendship Forged in Light
Brenda Power, columnist; Martin Cormican, Professor of Bacteriology, Medical School of University of Galway; David W. Higgins, Chief Economist at Carraighill; and Colette Bennett of Social Justice Ireland discuss the stories in the Sunday newspapers.
The Fertility Roadmap is here! Enroll now.Tracey brings over 20+ years of clinical practice, combining her foundational experience in Emergency Medicine and Primary Care with her current expertise in Women's Health. Tracey's inherent passion for patient care is integral to her approach in identifying and remedying underlying health issues, encompassing both traditional and functional medicine.Drawing on her expertise, she works with females, males and adolescents, focusing on general health, along with specific expertise in Hormonal Balance, Genetic Predisposition to Disease, Long Hauler Covid, Fertility, Metabolic Health, Gut Health, and General Nutrition Precision Health.Tracey graduated with a BS in Biology with a Minor in Chemistry, and a Masters in Bacteriology, Summa Cum Laude from Wagner College. She received her Physician's Assistant license and certification through St. John's University. She is certified in IV Nutrition, and an active member of CONNAPA and AAPA.Tracey lives in Connecticut with her husband and three children. She is active in her community, volunteering for breast cancer awareness causes, and is a prominent speaker on care of the aging female, as well as an adjunct clinical professor for both Marist and Quinnipiac Physician Assistant Programs.“Treating symptoms is secondary to uncovering the root cause of my patient's underlying health issues.”Connect with Tracey and Terrain Health: WebsiteThe Tempdrop makes charting your basal body temperature a breeze! Enjoy 10% when you order with code blissberrywellnessClick Here to Order NowUpcoming Episodes* Episode 024: Optimizing Fertility with the 4Rs with Nora DeBora, BSc CNP FAMMDisclaimer: This email is for educational purposes only and does not constitute medical advice. Please speak to your care provider before making any changes to your diet, lifestyle, or currently prescribed medications. *This email contains affiliate links. You will not be charged extra for purchasing through one of our links, but a small portion of the proceeds will go to support Baby Dust. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit babydust.substack.com
How do you connect the needs of researchers to the capabilities of technology? What are the main stages of research and the challenges faced at each stage? And will AI and machine learning speed up research and get solutions to market faster? We will learn those answers and more in this episode with Dr. Mark Hoffman, the Chief Research Information officer for Children's Mercy and the Children's Mercy Research Institute, a position he has held since 2016. Dr. Hoffman earned his doctorate in Bacteriology from the University of Wisconsin-Madison. He later joined Cerner as a software engineer where he advanced to the role of Vice President for Genomics and Research. Dr. Hoffman was also part of the faculty at the University of Missouri Kansas City (UMKC) in the Departments of Biomedical and Health Informatics and Pediatrics. His formal training in research and experience in software development has prepared him to connect the needs of researchers to the capabilities of technology. His work is focused on identifying the best capabilities possible to meet rapidly changing requirements in genomics, public health, and big data. Dr. Hoffman is an inventor of 22 issued patents, a member of the American Academy of Inventors, a TED talk alumnus, and an award-winning healthcare product developer. You can learn more about Dr. Hoffman and Children's Mercy here: https://www.childrensmercy.org Learn more about Oracle for Researcher here: http://www.oracle.com/research ---------------------------------------------------------- Episode Transcript 00;00;00;00 - 00;00;26;02 What are the three main stages of research and the challenges each are facing? How are researchers handling the new federal policies around data sharing? And will AI and machine learning speed research and get solutions to market faster? We'll get those answers and more on this episode of Research in Action. Hello and welcome back to Research in Action, brought to you by Oracle for Research. 00;00;26;02 - 00;00;49;21 I'm Mike Stiles. And today our guest is Dr. Mark Hoffman, who is the Chief Research Information Officer for Children's Mercy and the Children's Mercy Research Institute. That's a position he's held since 2016. Dr. Hoffman earned his doctorate in bacteriology from the University of Wisconsin-Madison and later joined Cerner as a software engineer, where he went on to be Vice President for genomics and research. 00;00;49;24 - 00;01;17;11 Dr. Hoffman was also part of the faculty at the University of Missouri, Kansas City, and the Departments of Biomedical and Health Informatics and Pediatrics. Now, because he's had formal training and research and real-world experience in software development, he's kind of uniquely qualified to talk about what researchers need when it comes to technology. His work focuses on identifying the best capabilities to meet requirements in genomics, public health and big data that are always changing. 00;01;17;14 - 00;01;38;22 He's an inventor of 95 issued patents, a member of the American Academy of Inventors, a TED Talk alumnus, and an award-winning health care product developer. And honest to gosh, that's about the shortest intro I could come up with for someone who is so accomplished. So, we're glad you are with us today, Dr. Hoffman. Well, thanks, Mike. I look forward to talking with you. 00;01;38;24 - 00;02;05;06 Our audience is going to be particularly lucky that they decided to stream this episode because there's a lot to cover. But first of all, what got you into research to begin with? Kind of what led you to each step along the way to where you are now at Children's Mercy? Well, it's a long story, but, you know, I think as a kid, I was always curious and I enjoyed Legos and, you know, taking things apart. 00;02;05;06 - 00;02;36;00 And so, in hindsight, I see all the foundations. And that took me a while to realize that my interests are really split between doing science and building technologies. And so, I see myself as very fortunate to have a role that lets me keep one foot in each of those areas of interest. So, you went when you made the decision to go to Cerner and go into that software development world. 00;02;36;02 - 00;03;05;24 What inspired you to do that? It's interesting. When I was in graduate school studying bacteriology, I was funded by an NIH program that if you're in the life sciences, you were required to take coursework outside the life sciences. I chose to do that in computer science. And then the other requirement was you were required to do an industry internship one summer. 00;03;05;26 - 00;03;31;27 Most of my peers chose to do that in pharma. I chose instead to do my internship at a software development company that does bioinformatics software development. Realized how much I liked that type of work and building things that get used in the real world. It's funny, but to this day, some of the features that I developed are still part of their application suite. 00;03;31;27 - 00;04;04;27 So, I learned from that that I enjoy the software and technology and development process. When there was the opportunity to join Cerner as a software engineer. I jumped at it and happened to be in their microbiology product line, so I was able to talk with the clients about what they were struggling with in the lab, understand that, and then translate that into whatever changes were needed in the software. 00;04;05;00 - 00;04;26;28 Did you expect that to be the case that you would be able to keep a foot in both sides on both the technology and the research side? Or was that something like you never thought that could happen? I didn't plan it this way, but I feel very fortunate that I'm able to exercise so many of my different interests. 00;04;27;00 - 00;05;12;19 So obviously children's mercy benefits from your professional expertise, but behind that you've got a real personal commitment and passion for the work that you're doing that kind of increases your value even more. If you're willing, tell us about that personal connection. And just in general, both Cerner and Children's Mercy are based in Kansas City. And as a parent, while I was working at Cerner, over time, both of our children have needed inpatient care at Children's Mercy Hospital and just the compassion and caring and quality of care and the creativity that we often saw with some of our children's physicians. 00;05;12;22 - 00;05;55;21 The willingness to keep trying things until they could help our kids work through their different health concerns has made a huge impression on me. Now, when I walk through the hospital and see parents with their kids who are going through really some of the most difficult situations you can imagine, I try to take a moment and share a smile or, you know, hold the elevator for a parent. I'm just trying to even though I'm not involved in patient care, I just really am empathetic to those families and see that as really kind of my connection to purpose. 00;05;55;24 - 00;06;35;13 What are the unique differences between a children's centered health care provider like that and, say, a regular adult hospital? What are the biggest differences that the staff has to operate with? I think probably the key difference is with adult medicine, you're really working primarily with the patient and they're making their own decisions. In pediatrics, you're working with children and they're their care providers so that there's more voices involved, you know, with younger children. 00;06;35;14 - 00;07;08;04 It's really is the care providers who are making those decisions with teenagers and adolescents, they certainly will have their own voice into the decision making. So that's really a key difference in pediatrics. I think pediatric medicine is interesting because it's both very cautious but also very willing to innovate. And I find that often to be a really interesting dynamic. 00;07;08;06 - 00;07;33;07 So you were a fan, as it were, of Children's Mercy before you started working there? Absolutely. That was a big part of my decision-making process to come here. So how did that come about that you started working for Children's Mercy? And what exactly do you do there? So, I made the difficult decision to move forward in my career in 2013. 00;07;33;09 - 00;07;58;04 The step that I took was to join the University of Missouri, Kansas City School of Medicine, join the faculty there and form what we called the Center of Health Insights. Through those negotiations, Children's Mercy funded 25% of my role at the university. And so, I already had not quite one foot, but at least a few toes in the door. 00;07;58;06 - 00;08;26;19 And I spent a lot of time building relationships with Children's Mercy. About three years into that, there was some hiring of senior leadership for the Research Institute, and I was involved in that and made the case that I'm seeing other organizations create the Chief Research Information Officer role. That idea stuck and I was hired as our first chief Research Information Officer. 00;08;26;21 - 00;08;50;09 So it sounds like what you want, what you're kind of your North star is to make sure researchers at Children's Mercy can tap into the best technical resources and experts out there, because especially medical researchers, everyone expects them to find answers quickly. You know, there are waiting to be helped. So. What's a typical day like for a chief research information officer? 00;08;50;12 - 00;09;27;09 I tell everybody there really is no typical day. Sometimes I'm down in the weeds talking through technical issues and then in the next meeting can be talking with organizational ownership about high level strategy. Part of what I enjoy is the variety in my role. I don't support any single clinical area of research. So, one meeting just yesterday was with our neurology department, where we're doing research into telemedicine and that can support rural communities where children have epilepsy. 00;09;27;11 - 00;09;55;25 And so there was that meeting and then there was another meeting within the same 24 hours about long read genomic sequencing with our genome center. So just context shifting and you know, always with the theme though, of trying to find ways for technology to be an enabler. All too often my peers in research feel that technology sometimes creates a barrier. 00;09;55;25 - 00;10;25;08 And so, one of my goals is just to try to reduce the barriers and increase the opportunities. And for you, it seems like, you know, you actually see the faces of the people that this research is trying to help. Does that add yet another motivational personal element behind kind of your mission there? Absolutely. I think through the pandemic, the entire work model for people in technology in particular has changed. 00;10;25;10 - 00;10;55;26 I know many of us spent a long time working from home and when I was able to start coming back on site, I just find it very motivating to go to the hospital cafeteria or, you know, get out of my research and technology bubble and be among the patients and families. Well, you've met researchers of every kind all over the world, people just like those who listen to this podcast and you know how they define success and also know what challenges they face. 00;10;55;28 - 00;11;25;06 I'll get to what those are in a second, but let's kind of define research. The stages are basic, translational and clinical. What exactly are those stages and how do you maneuver through those to get to actual innovation? I look at those where I see basic research as working with either molecules, cells or even animal models to understand the biological process. 00;11;25;09 - 00;11;57;14 And then the first level of translational research is taking a subset of those basic findings and exploring whether they may have a role to play in clinical practice. So sometimes that can also be where things start to be defined in an animal model. And then you start when something looks promising, you start working through early-stage clinical trials for safety, and then you start working with patient populations. 00;11;57;17 - 00;12;32;08 And then ultimately, if something's successful and does seem to benefit patients, then it gets rolled into practice and then there's an additional layer that we call outcomes research, where periodically it's important to review whether, you know, those new interventions or new tests really are making a positive difference in patient outcomes. That's kind of how I like to conceptualize the different phases of both basic and translational research. 00;12;32;10 - 00;13;06;17 Well, I'm assuming the challenges and opportunities are different depending on what kind of research we're talking about. So, let's start with your world of clinical research. What makes life unnecessarily harder for clinical researchers and does technology offer any help? I think no matter who I spoke with, recruitment into clinical trials is a continuing challenge. And I do think that data and technology have a helpful role to play in that. 00;13;06;20 - 00;13;37;07 Some of our work, as well as some work within Oracle or Oracle Health, is focused on using large de-identified data sets to evaluate the feasibility of doing research at a particular setting. Do they have enough patients who might meet the inclusion criteria? And so, I do think that data and technology have a role to play in the recruitment challenge. 00;13;37;10 - 00;14;05;23 That's kind of interesting that that recruiting for some of these trials is so difficult. What's the reluctance? You know, people have these conditions, it seems like they would be more than willing to try, you know, something? Why the reluctance? I think there's a number of factors. One is sometimes the designers of a study are maybe overly optimistic about the population. 00;14;05;26 - 00;14;36;01 Sometimes they underestimate the concerns that patients and their families may have. So that's one factor. I think as a scientific community, we need to continue working on how we communicate with the public, especially now, you know, with what I think of as the epidemic of mis- and dis-information. Those may not be preventing people from joining studies, but certainly they impact the willingness to utilize the benefits of research. 00;14;36;04 - 00;15;19;10 Yeah. Do you worry about the level of trust declining in health care researchers? I mean, the pandemic probably we took a hit with that. It's you know, that's a really interesting topic because on the one hand, I often reflect on the pandemic and if it had been ten years ago how different and much worse it would have been, because it really would have been unheard of to have in lab diagnostic tests within weeks, at home, testing within months, and a functional and safe vaccine within a year. 00;15;19;12 - 00;16;16;09 Ten years ago, that would not have been possible. And that's exclusively because of our capacity and in doing clinical research. I think, though, there's a lot of challenging dynamics in play that as a scientific community, we just need to keep getting out into the public, explaining in accessible terms what research is about and why it matters. One thing that we're very intentional about here at Children's Mercy is we have both parent and youth advisory boards, and so we work with them closely as we develop new research initiatives so that they're at the table and they're also out in the community, in the community, sharing the work that's happening here, because that's in so many ways 00;16;16;09 - 00;16;44;18 far more effective to hear from your neighbors, your friends at work than it is to hear from, you know, those of us who are doing the technical work. Well, kind of same question for those at the basic or fundamental research level, what are their biggest headaches? And, you know, is technology being applied to those headaches? Yeah, I think I wouldn't necessarily call them so much headaches. 00;16;44;18 - 00;17;21;07 But, you know, all categories of research, of course, feel that funding is always a challenge. I think for basic research, the volume of data that many techniques, not all, but many generate, creates an exciting opportunity for people who work in data science. For example, genomic sequencing, you know, is highly automated now, but the volume of data that any one genomic evaluation can generate is massive as well as, you know, very complex. 00;17;21;07 - 00;17;48;14 And so, the informatics and data science opportunities to analyze these growing volume of data is really exciting. Yeah, it feels like even though there are different research stages, there's obviously overlap when it comes to some of the roadblocks and opportunities to knock those roadblocks down. I mean, what do you see as kind of the shared pain points? You mentioned funding, I guess that goes across all stages. 00;17;48;17 - 00;18;27;09 Yeah, I think especially in a clinical setting there, there's a very high focus on cybersecurity. So, the research community is not always as involved in that as they probably needed to be. So, you know, we even have a lot of considerations that we incorporate into making sure that our systems, our data are secure to the highest standards. So that also my team tries to insulate the researchers from that type of work because we want them to be focused on doing science. 00;18;27;09 - 00;18;53;28 And in many organizations, we see researchers who have to get their hands in some of these other processes and technology issues. So a key part of what I see as my role and my team's role is insulating the researchers from those types of concerns. Yeah, which I'm sure they greatly appreciate. Obviously, there is a lot of compute resources that are required. 00;18;54;00 - 00;19;28;24 So, I imagine one of your challenges is to make sure these folks have the kind of compute resources they need. Yeah, and that's really an exciting area. We have recently completed the migration for our Genome Center of their bioinformatics pipeline from an on-premise data center to a completely cloud-based system. And we're excited that we're starting to see that gain of efficiencies from that, you know, moving that to a complete cloud model. 00;19;28;24 - 00;20;01;12 We have other projects that are more of a hybrid model. We do have a data center and our new research institute building. So, I'm excited about the new world where we can really offer computational and storage resources at a totally different scale than was needed ten years ago or even five years ago. Well, I know you're part of the Oracle Research Industry Strategy Council, a group that talked about a lot of the same stuff, pretty recently. 00;20;01;12 - 00;20;24;14 Just this May actually. So, one of the topics of discussion was how some researchers who are federally funded are kind of I don't know if struggling is the right word, but dealing with new policies around data storage and data sharing. The NIH has gotten real serious about those policies earlier this year. Why are these policies like FAIR principles coming down now? 00;20;24;17 - 00;20;56;13 And how ready are researchers to cope with those new protocols? Plus, whatever else may pop up in terms of regulation? Yeah, I think the change in policy reflects a realization on the funders that, you know, despite the expectation that researchers would share all of most of their data that was generated with those taxpayer funds, that that wasn't happening at the consistency level that they expected. 00;20;56;14 - 00;21;33;02 So, the major change this year is that that expectation is articulated much more forcefully. And so now anybody doing federally funded research is expected to make any data that does not include protected health information available to the community. I think some researchers are already doing that. So again, in the genomics world, that's already a fairly common practice. But in other areas it will require some change and different ways of thinking. 00;21;33;04 - 00;22;06;12 I'm not seeing a high level of anxiety or concern about it. I think it's something that we can work through. It's a matter of right sizing the solution. So, we don't want to oversize how we accommodate the new regulations, but we want to make sure that all of our researchers are equipped to be compliant. The reluctance that there is to data sharing is that just concerns about proprietary stuff or researchers are thinking about going to market with this. 00;22;06;12 - 00;22;31;02 And, you know, they want to keep it close to the vest. Sometimes that's the case. I think sometimes it's also academic competitive concerns. So, if you're competing for grant funding with the same people who could download your data, are you giving you know, there's concern that you're giving them, if not a head start, at least the capacity to catch up faster than they otherwise would have. 00;22;31;04 - 00;23;05;04 Does technology help in any way to adhere to these new policies and facilitate that kind of data sharing? I definitely believe it can. There's a variety of portals that can enable researchers to share their data. I think many of these have features that researchers like so that you can track how often your data assets are downloaded. In some cases, you can get a sense for, you know, where are the downloads originating. 00;23;05;07 - 00;23;39;10 What I think will be interesting over the next few years. Right now, in academia, tenure decisions are made based on publications and how often your papers are cited and so forth. I think if we can see a movement towards rewarding, how often is your data downloaded and accessed and utilized and rewarding, you know, academics that do that. I think that will be a real important factor in changing the culture around that. 00;23;39;12 - 00;24;04;28 So, in a couple of past episodes, I actually did ask our guests about this concept of open science that's grounded in FAIR principles. From what I've learned, open science doesn't mean, you know, anything goes, everybody dive in. It's all chaos. There is still scientific rigor. What does open science mean to you? What's open about it and what's still closed about it? 00;24;05;00 - 00;24;48;24 I think data sharing is a key part of open science, you know, and this is where having one foot in technology and one foot in science is helpful because if you look at the open-source software movement, there was very similar cultural resistance to that. But then as people realized that if you put your software code out for the public and they find and fix bugs in that code, that similar process can start to occur with scientific data where maybe there is an inconsistency or maybe there's a pattern in the data that you didn't recognize as, but somebody else does. 00;24;48;27 - 00;25;16;08 So, I think there's a lot to be learned from the process that the open-source software world witnessed and experienced. I think certainly in both cases, putting your either your code or your data out there as a vulnerable feeling for a lot of people. So, helping create a comfort level to get past that vulnerability is really important for the success of both. 00;25;16;08 - 00;25;44;21 But I think when you look at the long-term benefits of open science, I personally believe that the quality of work will go up. And when you pull it back to pediatrics, I think some of the very interesting work in pediatrics revolves around rare disease. And so no single organization is likely to have the numbers of patients with these rare diseases that they can independently gain the insights they need to. 00;25;44;21 - 00;26;13;12 So, collaborating and sharing data is essential for so many areas of pediatric research in particular. Well, for all the acronym fans out there, we talk about FAIR principles. That stands for findability, accessibility, interoperability and reusability. So yeah, I guess on a scale of 1 to 10, how close do you think we are to being FAIR? It'll vary from place to place, but I would just pull a number out of the air. 00;26;13;12 - 00;26;36;29 On average, I would give us a six or seven. Okay, already. Good. But probably going to get better is how I kind of interpret that answer. Yeah. So, one of the guests I pestered with the open science questions was Amy Dockser Marcus of the Wall Street Journal. She wrote a book called, “We The Scientists: How a Daring Team of Parents and Doctors Forged a New Path for Medicine.” 00;26;37;01 - 00;27;10;13 And basically, it's about patient-scientist-doctor collaborations and how that approach could get us to solutions faster. Do you see these collaborations happening? Are doctors and scientists more open to listening to and including patients and their caregivers? Yeah, I'm really seeing, you know, exciting changes in that. I mentioned earlier that we have patient and parent community advisory groups that are increasingly engaged and active in our research strategy. 00;27;10;16 - 00;27;44;14 And it's really shifting from just sometimes those initiatives start with us just telling those groups about what we're doing. But now it's really shifting to how can we do it better and how can we work through these barriers to recruitment, How can we make sure that we're reaching underserved populations? So, I find this whole engagement model to be a really exciting development, and it's really gaining much needed momentum. 00;27;44;16 - 00;28;12;13 And I find it inspiring and motivating to hear, you know, parents of children who have gone through a very difficult health conditions share their stories because that motivates me as well and motivates my colleagues. So, it really is an exciting development that's really picked up momentum. Well, thinking about the technology part, researchers kind of have to figure out what the appropriate tools are and deal with. 00;28;12;14 - 00;28;30;28 Okay, is this data I need and legacy on premises systems or can I get to it in the cloud? And you touched on this a little bit earlier about how you have a cloud solution, but you still also have some hybrid situations. Are you a hybrid guy or do you think all things in the cloud is the way to go? 00;28;30;28 - 00;29;02;13 Which way do you lean? My approach to everything is what are your requirements? And then I will help you fulfill your requirements. And so increasingly we can fulfill many of those requirements with an exclusively cloud-based model. Where it's interesting is that not only are there functional requirements, but there's cost requirements. And so, the hybrid model can often still be delivered with lower cost than a cloud exclusive model. 00;29;02;15 - 00;29;34;06 So, we're trying to be sensitive to the budgetary constraints of especially some of our early career investigators and offer a hybrid model to them as a way to get started without incurring the sometimes high costs of working in any of the major cloud providers. So, everybody in nearly every field that there is thinking about and talking about AI now and how it could change things dramatically. 00;29;34;08 - 00;29;59;06 What are you thinking about AI and machine learning when it comes to scientific research? Is it all positive and will it speed discovery and solutions getting to market? Or are you also waving the caution flag and trying to manage expectations? Because I think about how the combination of open science and it could get really interesting. 00;29;59;09 - 00;30;33;14 Yeah, I currently take a nuanced and cautious stance on AI and machine learning. If you're using those resources for data analysis, I see a lot of value to them. There's so many as we deal with these rapidly growing large datasets, the capacity of our minds to do the pattern recognition is limited. And so, AI and ML are great at pattern recognition in data. 00;30;33;14 - 00;31;24;04 And so, I think as a tool to support data analysis, I'm very positive. I worry more about the application and clinical practice of AI. I mean, being a member of the Ethical AI Initiative of the Center for Practical Bioethics in Kansas City, and I'm very impressed with the approach that they take and they deliver a workshop that is focused on if you're either buying a system that reports to be AI enabled or building something, what are the variety of ethical considerations that you should be considering? 00;31;24;06 - 00;31;55;11 And a particular area of concern is around health equity. And because we know that so many of these systems are trained on data sets that are skewed towards non-diverse populations. So, if that's what you're training these models with, and they will reinforce the inequities in health care. So, I think for some of those larger scale applications, we need to have a deliberate, careful and intentional approach. 00;31;55;13 - 00;32;22;24 It's not to say that there won't be positive uses of AI and ML, but I do think as we get closer to patient facing application, we need to be more intentional and more deliberate. Well, I want to be in a really good mood for the rest of the day, so could you tell us about research that's going on right now at Children's Mercy and some things that you're particularly excited about? 00;32;22;27 - 00;32;59;02 Yeah, and again, as I mentioned earlier, I really enjoy and thrive on the variety of work here. So I'm fortunate to collaborate, for example, with Dr. Bridgette Jones, who does research on health disparity and asthma. I'm fortunate to work with our Genome Center for Genomic Medicine, where they have a very large community facing project called Genomic Answers for Kids and focused on identifying the genetic basis for rare diseases. 00;32;59;05 - 00;33;28;23 I'm fortunate to collaborate with a wide group of experts on some of my own research where we use large de-identified clinical data from Oracle Health. So, two recent things we evaluated were how often and this is at a national level, are youth and young adults who present in the emergency room with a migraine, how often are they treated with an opioid? 00;33;28;25 - 00;33;59;29 The ideal would be 0 to 2%. We noticed that more than 20% of those youth and young adults nationally are treated with an opioid. So that type of research can then lend to process changes that challenge providers to reflect on their ordering patterns. So, the variety of really exciting research that we do at Children's Mercy is just something that excites me a lot. 00;34;00;03 - 00;34;32;15 Yeah, and on the genomics side, how close are we to, you know, all the exciting articles we read about the entire genome being mapped to the extent that we can go on and find the marker that is causing this rare disease and switch it off. Well, the very last part is where things get hard. But we've made huge strides in the recognition of the genetic basis for different rare health conditions. 00;34;32;18 - 00;35;09;01 Sometimes just finding that can lead to the realization that it's similar to a condition that presents differently but has a treatment available. And then you can try that medication on the patient with that genetic variant. And so those are the initial successes. I think the gene therapy type interventions that you might be alluding to, they're starting to regain some momentum, but that's going to be a long process. 00;35;09;04 - 00;35;42;17 So do you think people like me who just ask the question that I asked have over or heightened expectations? It's like, what is that balance between where the public thinks we should be and where actual research really is? Yeah, I think and that gets back to the even some of the societal topics that we were touching on earlier, where on the one hand there's elements of society that want research to move faster and to do more. 00;35;42;19 - 00;36;19;15 And then there's other elements that are much more of the go slow. And so, again, as a scientific community, finding that right balance and how we communicate about our work is really critical. And it's something that we really need to put an increased focus on to, you know, on the one hand, make sure that the advances that are complete and ready are utilized, which, you know, we all want that and that the emerging advances that people are participating in studies that they know that it is safe to participate in studies. 00;36;19;17 - 00;36;46;16 And then when the results of those studies are completed, that they're comfortable utilizing the output of that research. Well, for the last question, we'll stick with that societal aspect. You are an Oracle Council member, so you already know this, but Oracle believes that for the good of global health and humanity, we must understand and serve the needs of research and researchers at every level. 00;36;46;18 - 00;37;13;10 And it feels like we're facing bigger things like food security, disease prevention. Nobody needs another pandemic. What's your view on how research is only going to get more vital? And the pressure on research is only going to go up for kind of holding the earth and the species together? Yeah, that's a great question. And I am an optimist about research. 00;37;13;10 - 00;37;47;13 I believe that the work we do in research matters to the public and to the world. The examples you gave of food security, climate change, pandemics are all the, you know, major emerging concerns that all types of research are going to play a role in the solutions to those problems. And then I would pull us back to the question of how different would things have been if the pandemic had been ten years ago. 00;37;47;13 - 00;38;23;03 And to me, the research into many vaccines and rapid molecular diagnostics, those are all things that made the response to the pandemic. What it was, again, far from perfect, but much more effective than it would have been ten years ago were it not for all of the research that supported those developments. And I think that same mindset would apply to the other large scale problems and challenges that you mentioned. 00;38;23;05 - 00;38;44;00 Dr. Hoffman, thank you again for joining us today. You know, a lot of times our listeners will want to learn more about what you talked about or even get in touch with you. Is there any way they can do that? Sure. I'm on Twitter at Mark Hoffman K.C. I'm also on LinkedIn and my bio is available on the Children's Mercy website. 00;38;44;03 - 00;40;56;11 Great. We appreciate that. If you are interested in how Oracle can simplify and accelerate your research, you can check out Oracle dot com slash research. And join us next time on Research in Action.
This year's Conference On Engineering in Living Systems (CELS) happens this month and explores design principles at work in living things. To whet your appetite for the topic, we pulled this ID the Future from the archive. Host Jonathan Witt gives us a behind-the-scenes interview with Dustin Van Hofwegen, a biology professor at Azusa Pacific University in California. The occasion was a previous Conference on Engineering in Living Systems. The two discuss the private event, which brought together biologists and engineers to study how engineering principles and a design perspective can and are being applied to biology — to plants and animals but also to Van Hofwegen's area of focus, the realm of microbial biology. The two quickly move into a conversation about Van Hofwegen's article in the Journal of Bacteriology, co-authored with Carolyn Hovde and Scott Minnich, based on research they did at the University of Idaho. As Van Hofwegen explains, the research focused on one of the most ballyhooed evolutionary changes to come out of Richard Lenski's long-term evolution experiment, a decades-long study of many thousands of generations of E. coli bacteria. Perhaps the biggest evolutionary development in the course of the experiment involved some bacteria beginning to feed in citric acid. Interesting, to be sure, but as Van Hofwegen explains, E. coli already has this capacity; it's just a matter of switching it on. Van Hofwegen, Hovde, and Minnich demonstrated this through do-or-die experiments with E. coli, which led to the bacteria developing the capacity not in years or decades, as in the Lenski experiment, but in fourteen days, in as little as 100 generations. Van Hofwegen unpacks why this is an embarrassing result for Neo-Darwinism. The pair conclude with discussion of another study on antibiotic resistance with a similar result, that the resistance observed came not by evolving anything new but by tweaking something already present. Source
A erradicação da varíola por meio da vacinação. Uma das doenças mais devastadoras da história da humanidade - a varíola. Separe meia horinha do seu dia e descubra, com a Mila Massuda, os avanços científicos responsáveis pela nossa sobrevivência diante desta implacável adversária. Apresentação: Mila Massuda (@milamassuda) Roteiro: Mila Massuda (@milamassuda) e Emilio Garcia (@emilioblablalogia) Edição: @Matheus_Herédia (@mewmediaLAB) Produção: Prof. Vítor Soares (@profvitorsoares) e BláBláLogia (@blablalogia) REFERÊNCIAS: KOTAR, S. L.; GESSLER, J. E. Smallpox: a history. McFarland, 2013. HOPKINS, Donald R.; LYTHCOTT, George I. Princes and peasants: smallpox in history. Chicago: University of Chicago Press, 1983. RUFFER, M. Armand; FERGUSON, A. R. Note on an eruption resembling that of variola in the skin of a mummy of the twentieth dynasty (1200–1100 BC). The Journal of Pathology and Bacteriology, v. 15, n. 1, p. 1-3, 191
Professor of Bacteriology in University of Galway, Martin Cormican speaks to Brendan about the importance of reviewing lockdown measures post - Covid.
Andrew Huberman, Professor of Microbiology at the University of Pennsylvania, and author of the book A Higher Kind of Science: The Important Ideas Behind Modern Biochemistry discusses the concept of metempirics in bacteriology.
Michael Mina is a bacteriologist who specializes in understanding the genetic mechanisms that cause bacteria to become diseases. He also has a keen interest in the history and meaning of verse and hegemonism. In this episode, Lexman and Mina discuss these topics in an engaging, insightful conversation.
Antimicrobial susceptibility testing comes in a number of different formats. On this episode, Microbe Mail host Dr Vindana Chibabhai speaks to Dr Warren Lowman about MICs - minimum inhibitory concentrations...how they are derived, why and when they are important to consider. YOUR FEEDBACK ON THIS EPISODE – https://docs.google.com/forms/d/e/1FAIpQLScMGGgx-KFmeZoRuJW0OMxM-i4mRqSIwgaAl7afAxvIO3wmuw/viewform?usp=sf_link (HERE!) About our Guest: I am a pathologist in microbiology passionate about bugs with a particular focus on the clinical application and integration of microbiological diagnostic services in specialized medical care. Bacteriology is my first love and I have a particular interest in hospital pathogens and the associated diagnostic and antimicrobial treatment aspects of these bugs. Surveillance of hospital-acquired infections and the application of data derived from hospital surveillance systems is another key focus area. I am actively involved in these activities on a daily basis where I balance my time between laboratory-based diagnostic work and clinical ward rounds focusing on ICU/transplant-related microbiology and infection prevention and control aspects. I am actively involved in numerous academic-related activities, am the current chairperson of the South African Society of Clinical Microbiology, and am passionate about sharing knowledge in the field. Outside of work I am kept busy by my 3 sons, wonderful wife, nature, cooking and the odd-game of golf! Microbiological interests: 1. ICU-related antimicrobial therapy a. Clinical/ patient issues related to pharmacodynamics and pharmacokinetics. b. Antimicrobial susceptibility testing and its application to treatment of critically ill patients 2. Transplant Microbiology and Infectious Diseases 3. Infection Prevention and Control a. Hospital surveillance systems b. Healthcare-associated pathogens 4. Antimicrobial Susceptibility Testing Links: Wits Donald Gordon Medical Centre https://www.linkedin.com/company/wits-donald-gordon-medical-centre-pty-limited/?originalSubdomain=za (LinkedIn) and https://www.facebook.com/Wits-Donald-Gordon-Medical-Centre-118831771471611/ (Facebook) Pathcare https://www.pathcare.co.za/ (website) and https://www.linkedin.com/company/pathcare/?originalSubdomain=za (LinkedIn ) Visit the Microbe Mail https://microbemail.captivate.fm/ (website) to sign up for updates E-mail: mail.microbe@gmail.com YouTube: https://www.youtube.com/channel/UCgaP3aUNkjrgOxR8Ei6UaEw (Microbe Mail) Instagram: https://instagram.com/https:/www.instagram.com/microbe_mail/ (Microbe_Mail) Check out https://pin.it/2Krw0r4 (Pinterest) for our Storyboards @mailmicrobe
Today we're doing a 15-minute super high-yield Microbiology drill session covering the basic principles of Bacteriology.This is the kind of stuff that we often overlook, but that can help us significantly boost our USMLE Step 1 scores.If you enjoyed the drill and want more just like it, check out our USMLE Step 1 drills book by visiting USMLEDRILLS.COMThanks for listening!Follow me on YouTube for even more USMLE training at theusmleguys.com/ytFind me on IG and say hello --> @realdrpaulUntil next time!
Stand Up is a daily podcast. I book,host,edit, post and promote new episodes with brilliant guests every day. Please subscribe now for as little as 5$ and gain access to a community of over 800 awesome, curious, kind, funny, brilliant, generous souls Check out StandUpwithPete.com to learn more Indeed.com/STANDUP 30 mins Eugene Linden is an award-winning journalist and author on science, nature, and the environment. He is the author of nine books of non-fiction and one novel. His previous book on climate change, Winds of Change, explored the connection between climate change and the rise and fall of civilizations, and was awarded the Grantham Prize Special Award of Merit. His celebrated works on animal intelligence include Apes, Men, and Language, the New York Times “Notable Book” Silent Partners, and the bestselling The Parrot's Lament. For many years, Eugene wrote about nature and global environmental issues for TIME where he garnered several awards including the American Geophysical Union's Walter Sullivan Award. He has also contributed to the New York Times, Foreign Affairs, and National Geographic, among many other publications. 50 mins Dr. Meghan May was appointed in the Department of Biomedical Sciences at the University of New England College of Medicine in 2013. She was previously appointed in the Department of Biological Sciences at Towson University from 2010-2013, and held the Fisher Endowed Chair of Biological Sciences from 2012-2013, and was appointed as a postdoctoral fellow and then a research assistant professor in the Department of Infectious Diseases and Pathology at the University of Florida. Dr. May earned her B.S. degree in Microbiology from the University of New Hampshire, and her M.S. and Ph.D. degrees in Pathobiology and Bacteriology (respectively) from the University of Connecticut. Her research focus is on the evolution of virulence, not only to determine how new diseases appear and where they come from but also how to predict what new disease might arise next — pathogen forecasting Follow her on Twitter All things Jon Carroll Follow and Support Pete Coe Pete on YouTube Pete on Twitter Pete On Instagram Pete Personal FB page Stand Up with Pete FB page
Welcome to the 423nd episode of COVID-Calls, a daily discussion of the COVID-19 pandemic with a diverse collection of disaster experts. My name is Jacob Steere-Williams, I am a historian of public health at the College of Charleston, in South Carolina, and I'm thrilled to be hosting the program this week. Dr. Susan Jones is the Distinguished McKnight University Pressor in Ecology, Evolution, and Behavior, and in the History of Science, Technology, and Medicine at the University of Minnesota. Trained first as a Doctor of Veterinary Medicine, Dr. Jones also received a PhD in the history of science and medicine at Penn. Her expertise is the historical ecology of disease, comparative and environmental health, and human-animal relationships. Dr. Jones is the recipient of both Guggenheim and Fullbright Fellowships, and is the author of the 2003 book Valuing Animals: Veterinarians and their Patients in Modern America, the 2010 book Death in a Small Package: A Short History of Anthrax, and dozens of scholarly articles and book chapters. She currently is working on a global environmental history of plague. Dr. Pratik Chakrabarti is the Cullen NEH Chair in History at the University of Houston. He has written extensively on the history of science, medicine, and imperialism in South Asia, the Atlantic World, and the Caribbean from the 18th to the 20th centuries. Dr. Chakrabarti is the author of several stunning books, including Western Science in Modern India (2004), Materials and Medicine (2010), Bacteriology in British India (2012), and the 2020 book, Inscriptions of Nature: Geology and the Naturalization of Antiquity. For several years he was both the Director of the Center for the History of Science, Technology, and Medicine at the University of Manchester in the UK, and editor of the journal Social History of Medicine. Pratik is currently working on the history of postcolonial public health in India and on a project about global vaccine research.
Aro Velmet's Pasteur's Empire: Bacteriology in France, Its Colonies, and the World (Oxford UP, 2020) is a complex history of the Pasteur Institutes, a network of scientific laboratories established in France and throughout the French empire, beginning in the last decade of the nineteenth century. The book examines the crucial roles Pastorians and Pasteurization played in the imperial project in and between different locations, particularly in Southeast Asia and Africa. Participating in the "civilizing mission," helping to establish and maintain industrial monopolies, and the control of colonial bodies through public health regulation and disease management, the institutes had a tremendous political impact. Attentive to the experiences and perspectives of the Vietnamese and African peoples in the sites the book focuses on, Pasteur's Empire examines a range of scientific responses and measures, from the study and containment of infectious and epidemic disease to the microbiological aspects of industry. The book's chapters move from "Indochina" to North and West Africa, tracing the way that Pastorians and Pasteurization worked with(in) and sometimes pushed against colonial structures and assumptions. French modernity and the "civilizing mission" had profound and practical biological dimensions. A history that pursues ideas about modernity and the meanings of scientific and other forms of mobility, Pasteur's Empire moves from the local to the global while bringing together science, medicine, and politics. Enjoy the episode! Roxanne Panchasi is an Associate Professor of History at Simon Fraser University in Vancouver, Canada who specializes in twentieth and twenty-first century France and its empire. If you have a recent title to suggest for the podcast, please send her an email (panchasi@sfu.ca). Learn more about your ad choices. Visit megaphone.fm/adchoices
Aro Velmet's Pasteur's Empire: Bacteriology in France, Its Colonies, and the World (Oxford UP, 2020) is a complex history of the Pasteur Institutes, a network of scientific laboratories established in France and throughout the French empire, beginning in the last decade of the nineteenth century. The book examines the crucial roles Pastorians and Pasteurization played in the imperial project in and between different locations, particularly in Southeast Asia and Africa. Participating in the "civilizing mission," helping to establish and maintain industrial monopolies, and the control of colonial bodies through public health regulation and disease management, the institutes had a tremendous political impact. Attentive to the experiences and perspectives of the Vietnamese and African peoples in the sites the book focuses on, Pasteur's Empire examines a range of scientific responses and measures, from the study and containment of infectious and epidemic disease to the microbiological aspects of industry. The book's chapters move from "Indochina" to North and West Africa, tracing the way that Pastorians and Pasteurization worked with(in) and sometimes pushed against colonial structures and assumptions. French modernity and the "civilizing mission" had profound and practical biological dimensions. A history that pursues ideas about modernity and the meanings of scientific and other forms of mobility, Pasteur's Empire moves from the local to the global while bringing together science, medicine, and politics. Enjoy the episode! Roxanne Panchasi is an Associate Professor of History at Simon Fraser University in Vancouver, Canada who specializes in twentieth and twenty-first century France and its empire. If you have a recent title to suggest for the podcast, please send her an email (panchasi@sfu.ca). Learn more about your ad choices. Visit megaphone.fm/adchoices
Aro Velmet's Pasteur's Empire: Bacteriology in France, Its Colonies, and the World (Oxford UP, 2020) is a complex history of the Pasteur Institutes, a network of scientific laboratories established in France and throughout the French empire, beginning in the last decade of the nineteenth century. The book examines the crucial roles Pastorians and Pasteurization played in the imperial project in and between different locations, particularly in Southeast Asia and Africa. Participating in the "civilizing mission," helping to establish and maintain industrial monopolies, and the control of colonial bodies through public health regulation and disease management, the institutes had a tremendous political impact. Attentive to the experiences and perspectives of the Vietnamese and African peoples in the sites the book focuses on, Pasteur's Empire examines a range of scientific responses and measures, from the study and containment of infectious and epidemic disease to the microbiological aspects of industry. The book's chapters move from "Indochina" to North and West Africa, tracing the way that Pastorians and Pasteurization worked with(in) and sometimes pushed against colonial structures and assumptions. French modernity and the "civilizing mission" had profound and practical biological dimensions. A history that pursues ideas about modernity and the meanings of scientific and other forms of mobility, Pasteur's Empire moves from the local to the global while bringing together science, medicine, and politics. Enjoy the episode! Roxanne Panchasi is an Associate Professor of History at Simon Fraser University in Vancouver, Canada who specializes in twentieth and twenty-first century France and its empire. If you have a recent title to suggest for the podcast, please send her an email (panchasi@sfu.ca). Learn more about your ad choices. Visit megaphone.fm/adchoices
Aro Velmet's Pasteur's Empire: Bacteriology in France, Its Colonies, and the World (Oxford UP, 2020) is a complex history of the Pasteur Institutes, a network of scientific laboratories established in France and throughout the French empire, beginning in the last decade of the nineteenth century. The book examines the crucial roles Pastorians and Pasteurization played in the imperial project in and between different locations, particularly in Southeast Asia and Africa. Participating in the "civilizing mission," helping to establish and maintain industrial monopolies, and the control of colonial bodies through public health regulation and disease management, the institutes had a tremendous political impact. Attentive to the experiences and perspectives of the Vietnamese and African peoples in the sites the book focuses on, Pasteur's Empire examines a range of scientific responses and measures, from the study and containment of infectious and epidemic disease to the microbiological aspects of industry. The book's chapters move from "Indochina" to North and West Africa, tracing the way that Pastorians and Pasteurization worked with(in) and sometimes pushed against colonial structures and assumptions. French modernity and the "civilizing mission" had profound and practical biological dimensions. A history that pursues ideas about modernity and the meanings of scientific and other forms of mobility, Pasteur's Empire moves from the local to the global while bringing together science, medicine, and politics. Enjoy the episode! Roxanne Panchasi is an Associate Professor of History at Simon Fraser University in Vancouver, Canada who specializes in twentieth and twenty-first century France and its empire. If you have a recent title to suggest for the podcast, please send her an email (panchasi@sfu.ca). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine
Aro Velmet's Pasteur's Empire: Bacteriology in France, Its Colonies, and the World (Oxford UP, 2020) is a complex history of the Pasteur Institutes, a network of scientific laboratories established in France and throughout the French empire, beginning in the last decade of the nineteenth century. The book examines the crucial roles Pastorians and Pasteurization played in the imperial project in and between different locations, particularly in Southeast Asia and Africa. Participating in the "civilizing mission," helping to establish and maintain industrial monopolies, and the control of colonial bodies through public health regulation and disease management, the institutes had a tremendous political impact. Attentive to the experiences and perspectives of the Vietnamese and African peoples in the sites the book focuses on, Pasteur's Empire examines a range of scientific responses and measures, from the study and containment of infectious and epidemic disease to the microbiological aspects of industry. The book's chapters move from "Indochina" to North and West Africa, tracing the way that Pastorians and Pasteurization worked with(in) and sometimes pushed against colonial structures and assumptions. French modernity and the "civilizing mission" had profound and practical biological dimensions. A history that pursues ideas about modernity and the meanings of scientific and other forms of mobility, Pasteur's Empire moves from the local to the global while bringing together science, medicine, and politics. Enjoy the episode! Roxanne Panchasi is an Associate Professor of History at Simon Fraser University in Vancouver, Canada who specializes in twentieth and twenty-first century France and its empire. If you have a recent title to suggest for the podcast, please send her an email (panchasi@sfu.ca). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science
Aro Velmet's Pasteur's Empire: Bacteriology in France, Its Colonies, and the World (Oxford UP, 2020) is a complex history of the Pasteur Institutes, a network of scientific laboratories established in France and throughout the French empire, beginning in the last decade of the nineteenth century. The book examines the crucial roles Pastorians and Pasteurization played in the imperial project in and between different locations, particularly in Southeast Asia and Africa. Participating in the "civilizing mission," helping to establish and maintain industrial monopolies, and the control of colonial bodies through public health regulation and disease management, the institutes had a tremendous political impact. Attentive to the experiences and perspectives of the Vietnamese and African peoples in the sites the book focuses on, Pasteur's Empire examines a range of scientific responses and measures, from the study and containment of infectious and epidemic disease to the microbiological aspects of industry. The book's chapters move from "Indochina" to North and West Africa, tracing the way that Pastorians and Pasteurization worked with(in) and sometimes pushed against colonial structures and assumptions. French modernity and the "civilizing mission" had profound and practical biological dimensions. A history that pursues ideas about modernity and the meanings of scientific and other forms of mobility, Pasteur's Empire moves from the local to the global while bringing together science, medicine, and politics. Enjoy the episode! Roxanne Panchasi is an Associate Professor of History at Simon Fraser University in Vancouver, Canada who specializes in twentieth and twenty-first century France and its empire. If you have a recent title to suggest for the podcast, please send her an email (panchasi@sfu.ca). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network
Aro Velmet's Pasteur's Empire: Bacteriology in France, Its Colonies, and the World (Oxford UP, 2020) is a complex history of the Pasteur Institutes, a network of scientific laboratories established in France and throughout the French empire, beginning in the last decade of the nineteenth century. The book examines the crucial roles Pastorians and Pasteurization played in the imperial project in and between different locations, particularly in Southeast Asia and Africa. Participating in the "civilizing mission," helping to establish and maintain industrial monopolies, and the control of colonial bodies through public health regulation and disease management, the institutes had a tremendous political impact. Attentive to the experiences and perspectives of the Vietnamese and African peoples in the sites the book focuses on, Pasteur's Empire examines a range of scientific responses and measures, from the study and containment of infectious and epidemic disease to the microbiological aspects of industry. The book's chapters move from "Indochina" to North and West Africa, tracing the way that Pastorians and Pasteurization worked with(in) and sometimes pushed against colonial structures and assumptions. French modernity and the "civilizing mission" had profound and practical biological dimensions. A history that pursues ideas about modernity and the meanings of scientific and other forms of mobility, Pasteur's Empire moves from the local to the global while bringing together science, medicine, and politics. Enjoy the episode! Roxanne Panchasi is an Associate Professor of History at Simon Fraser University in Vancouver, Canada who specializes in twentieth and twenty-first century France and its empire. If you have a recent title to suggest for the podcast, please send her an email (panchasi@sfu.ca). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/african-studies
Aro Velmet's Pasteur's Empire: Bacteriology in France, Its Colonies, and the World (Oxford UP, 2020) is a complex history of the Pasteur Institutes, a network of scientific laboratories established in France and throughout the French empire, beginning in the last decade of the nineteenth century. The book examines the crucial roles Pastorians and Pasteurization played in the imperial project in and between different locations, particularly in Southeast Asia and Africa. Participating in the "civilizing mission," helping to establish and maintain industrial monopolies, and the control of colonial bodies through public health regulation and disease management, the institutes had a tremendous political impact. Attentive to the experiences and perspectives of the Vietnamese and African peoples in the sites the book focuses on, Pasteur's Empire examines a range of scientific responses and measures, from the study and containment of infectious and epidemic disease to the microbiological aspects of industry. The book's chapters move from "Indochina" to North and West Africa, tracing the way that Pastorians and Pasteurization worked with(in) and sometimes pushed against colonial structures and assumptions. French modernity and the "civilizing mission" had profound and practical biological dimensions. A history that pursues ideas about modernity and the meanings of scientific and other forms of mobility, Pasteur's Empire moves from the local to the global while bringing together science, medicine, and politics. Enjoy the episode! Roxanne Panchasi is an Associate Professor of History at Simon Fraser University in Vancouver, Canada who specializes in twentieth and twenty-first century France and its empire. If you have a recent title to suggest for the podcast, please send her an email (panchasi@sfu.ca). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/french-studies
Aro Velmet's Pasteur's Empire: Bacteriology in France, Its Colonies, and the World (Oxford UP, 2020) is a complex history of the Pasteur Institutes, a network of scientific laboratories established in France and throughout the French empire, beginning in the last decade of the nineteenth century. The book examines the crucial roles Pastorians and Pasteurization played in the imperial project in and between different locations, particularly in Southeast Asia and Africa. Participating in the "civilizing mission," helping to establish and maintain industrial monopolies, and the control of colonial bodies through public health regulation and disease management, the institutes had a tremendous political impact. Attentive to the experiences and perspectives of the Vietnamese and African peoples in the sites the book focuses on, Pasteur's Empire examines a range of scientific responses and measures, from the study and containment of infectious and epidemic disease to the microbiological aspects of industry. The book's chapters move from "Indochina" to North and West Africa, tracing the way that Pastorians and Pasteurization worked with(in) and sometimes pushed against colonial structures and assumptions. French modernity and the "civilizing mission" had profound and practical biological dimensions. A history that pursues ideas about modernity and the meanings of scientific and other forms of mobility, Pasteur's Empire moves from the local to the global while bringing together science, medicine, and politics. Enjoy the episode! Roxanne Panchasi is an Associate Professor of History at Simon Fraser University in Vancouver, Canada who specializes in twentieth and twenty-first century France and its empire. If you have a recent title to suggest for the podcast, please send her an email (panchasi@sfu.ca). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history
Aro Velmet's Pasteur's Empire: Bacteriology in France, Its Colonies, and the World (Oxford UP, 2020) is a complex history of the Pasteur Institutes, a network of scientific laboratories established in France and throughout the French empire, beginning in the last decade of the nineteenth century. The book examines the crucial roles Pastorians and Pasteurization played in the imperial project in and between different locations, particularly in Southeast Asia and Africa. Participating in the "civilizing mission," helping to establish and maintain industrial monopolies, and the control of colonial bodies through public health regulation and disease management, the institutes had a tremendous political impact. Attentive to the experiences and perspectives of the Vietnamese and African peoples in the sites the book focuses on, Pasteur's Empire examines a range of scientific responses and measures, from the study and containment of infectious and epidemic disease to the microbiological aspects of industry. The book's chapters move from "Indochina" to North and West Africa, tracing the way that Pastorians and Pasteurization worked with(in) and sometimes pushed against colonial structures and assumptions. French modernity and the "civilizing mission" had profound and practical biological dimensions. A history that pursues ideas about modernity and the meanings of scientific and other forms of mobility, Pasteur's Empire moves from the local to the global while bringing together science, medicine, and politics. Enjoy the episode! Roxanne Panchasi is an Associate Professor of History at Simon Fraser University in Vancouver, Canada who specializes in twentieth and twenty-first century France and its empire. If you have a recent title to suggest for the podcast, please send her an email (panchasi@sfu.ca). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/middle-eastern-studies
Aro Velmet's Pasteur's Empire: Bacteriology in France, Its Colonies, and the World (Oxford UP, 2020) is a complex history of the Pasteur Institutes, a network of scientific laboratories established in France and throughout the French empire, beginning in the last decade of the nineteenth century. The book examines the crucial roles Pastorians and Pasteurization played in the imperial project in and between different locations, particularly in Southeast Asia and Africa. Participating in the "civilizing mission," helping to establish and maintain industrial monopolies, and the control of colonial bodies through public health regulation and disease management, the institutes had a tremendous political impact. Attentive to the experiences and perspectives of the Vietnamese and African peoples in the sites the book focuses on, Pasteur's Empire examines a range of scientific responses and measures, from the study and containment of infectious and epidemic disease to the microbiological aspects of industry. The book's chapters move from "Indochina" to North and West Africa, tracing the way that Pastorians and Pasteurization worked with(in) and sometimes pushed against colonial structures and assumptions. French modernity and the "civilizing mission" had profound and practical biological dimensions. A history that pursues ideas about modernity and the meanings of scientific and other forms of mobility, Pasteur's Empire moves from the local to the global while bringing together science, medicine, and politics. Enjoy the episode! Roxanne Panchasi is an Associate Professor of History at Simon Fraser University in Vancouver, Canada who specializes in twentieth and twenty-first century France and its empire. If you have a recent title to suggest for the podcast, please send her an email (panchasi@sfu.ca). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/southeast-asian-studies
Aro Velmet's Pasteur's Empire: Bacteriology in France, Its Colonies, and the World (Oxford UP, 2020) is a complex history of the Pasteur Institutes, a network of scientific laboratories established in France and throughout the French empire, beginning in the last decade of the nineteenth century. The book examines the crucial roles Pastorians and Pasteurization played in the imperial project in and between different locations, particularly in Southeast Asia and Africa. Participating in the "civilizing mission," helping to establish and maintain industrial monopolies, and the control of colonial bodies through public health regulation and disease management, the institutes had a tremendous political impact. Attentive to the experiences and perspectives of the Vietnamese and African peoples in the sites the book focuses on, Pasteur's Empire examines a range of scientific responses and measures, from the study and containment of infectious and epidemic disease to the microbiological aspects of industry. The book's chapters move from "Indochina" to North and West Africa, tracing the way that Pastorians and Pasteurization worked with(in) and sometimes pushed against colonial structures and assumptions. French modernity and the "civilizing mission" had profound and practical biological dimensions. A history that pursues ideas about modernity and the meanings of scientific and other forms of mobility, Pasteur's Empire moves from the local to the global while bringing together science, medicine, and politics. Enjoy the episode! Roxanne Panchasi is an Associate Professor of History at Simon Fraser University in Vancouver, Canada who specializes in twentieth and twenty-first century France and its empire. If you have a recent title to suggest for the podcast, please send her an email (panchasi@sfu.ca).
Aro Velmet's Pasteur's Empire: Bacteriology in France, Its Colonies, and the World (Oxford UP, 2020) is a complex history of the Pasteur Institutes, a network of scientific laboratories established in France and throughout the French empire, beginning in the last decade of the nineteenth century. The book examines the crucial roles Pastorians and Pasteurization played in the imperial project in and between different locations, particularly in Southeast Asia and Africa. Participating in the "civilizing mission," helping to establish and maintain industrial monopolies, and the control of colonial bodies through public health regulation and disease management, the institutes had a tremendous political impact. Attentive to the experiences and perspectives of the Vietnamese and African peoples in the sites the book focuses on, Pasteur's Empire examines a range of scientific responses and measures, from the study and containment of infectious and epidemic disease to the microbiological aspects of industry. The book's chapters move from "Indochina" to North and West Africa, tracing the way that Pastorians and Pasteurization worked with(in) and sometimes pushed against colonial structures and assumptions. French modernity and the "civilizing mission" had profound and practical biological dimensions. A history that pursues ideas about modernity and the meanings of scientific and other forms of mobility, Pasteur's Empire moves from the local to the global while bringing together science, medicine, and politics. Enjoy the episode! Roxanne Panchasi is an Associate Professor of History at Simon Fraser University in Vancouver, Canada who specializes in twentieth and twenty-first century France and its empire. If you have a recent title to suggest for the podcast, please send her an email (panchasi@sfu.ca). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/book-of-the-day
Today's high-yield USMLE drill session will cover the highest-yield information that you need to know for your Step 1 exam under the topic of 'The Basics of Bacteriology', which is found in your First Aid under the Microbiology section.If you want to access our FULL LIBRARY of high-yield USMLE Step 1 Drill Sessions, be sure to visit either USMLEGUYS.com or USMLEDRILLS.com to learn more.Check us out on YouTube, where we post medical school & USMLE-related educational videos at least 3x/week. Visit us here: https://youtube.com/c/TheUSMLEPreparationCompanyFollow Dr. Paul on IG at instagram.com/realdrpaulFollow Dr. Stavros on IG at instagram.com/realdrstavros
Stand Up is a daily podcast. I book,host,edit, post and promote new episodes with brilliant guests every day. Please subscribe now for as little as 5$ and gain access to a community of over 800 awesome, curious, kind, funny, brilliant, generous souls Check out StandUpwithPete.com to learn more I have a great news recap for you on all things Omnicron and more then at 32 minutes my interview with Dr Meghan May starts and I begin with JL Cauvin at 1:05 On today's show I announced my first Stand Up Comedy date with Ophira Eisenberg and Christian Finnegan for Saturday January 15 2021 in King of Prussia PA Please support my sponsors All this month and next I will be promoting GiveWell.org and I hope you will consider sending them a donation. They will match new donors up to $250! Please go to GiveWell.org/StandUp TommyJohn.com/STANDUP GetQuip.com/STANDUP Indeed.com/STANDUP Dr. Meghan May was appointed in the Department of Biomedical Sciences at the University of New England College of Medicine in 2013. She was previously appointed in the Department of Biological Sciences at Towson University from 2010-2013, and held the Fisher Endowed Chair of Biological Sciences from 2012-2013, and was appointed as a postdoctoral fellow and then a research assistant professor in the Department of Infectious Diseases and Pathology at the University of Florida. Dr. May earned her B.S. degree in Microbiology from the University of New Hampshire, and her M.S. and Ph.D. degrees in Pathobiology and Bacteriology (respectively) from the University of Connecticut. Her research focus is on the evolution of virulence, not only to determine how new diseases appear and where they come from but also how to predict what new disease might arise next — pathogen forecasting Follow her on Twitter JL Cauvin is the best Trump impersonator in the world. He is also a very talented Stand Up Comic with who I have known for a long time. JL has recorded 6 stand up albums! J-L's act is incredibly diverse and has led to six stand up albums: 2006′s Racial Chameleon, 2008′s Diamond Maker, 2012′s Too Big To Fail and 2013′s Keep My Enemies Closer, 2016's Israeli Tortoise, which hit #1 on the iTunes comedy chart and his 2018 double album Thots & Prayers. He has also released two albums as Donald Trump: 2017's Fireside Craps, an entire album as Donald Trump which hit #1 on the iTunes comedy chart and 2020's Fireside Craps: The Deuce which went #1 on both Amazon and iTunes' comedy charts and broke into the Top 40 on iTunes' overall album charts. JL is the host of 2 podcasts "Righteous Prick" and "Making Podcasts Great Again" ----------------- Check out all things Jon Carroll Follow and Support Pete Coe Pete on YouTube Pete on Twitter Pete On Instagram Pete Personal FB page
Take a trip with me down memory lane where I share my travel experiences through Nepal to endeavour Annapurna and Everest Base Camp treks. This country transformed my outlook on life in copious ways and helped me to connect with my spiritually side.Discover Nepalese singing bowls and the theory behind their vibrational healing ability. I will also provide information on Dr Royal Raymond Rife, a Bacteriology scientist who invented a machine to devitalise diseased organisms using electromagnetic frequency.
Stand Up is a daily podcast. I book,host,edit, post and promote new episodes with brilliant guests every day. Please subscribe now for as little as 5$ and gain access to a community of over 800 awesome, curious, kind, funny, brilliant, generous souls Check out StandUpwithPete.com to learn more 29 minutes Michael A. Cohen is a regular contributor for The Boston Globe on national politics and foreign affairs. He is also the author of “American Maelstrom: The 1968 Election and the Politics of Division.” Michael has written for dozens of news outlets, including as a columnist for the Guardian and Foreign Policy and he is the US Political Correspondent for the London Observer. He previously worked as a speechwriter at the US State Department and has been a lecturer at Columbia University's School of International and Public Affairs. Stand Up subscribers get a discount on Michael's new newsletter! 1:00 Dr. Meghan May was appointed in the Department of Biomedical Sciences at the University of New England College of Medicine in 2013. She was previously appointed in the Department of Biological Sciences at Towson University from 2010-2013, and held the Fisher Endowed Chair of Biological Sciences from 2012-2013, and was appointed as a postdoctoral fellow and then a research assistant professor in the Department of Infectious Diseases and Pathology at the University of Florida. Dr. May earned her B.S. degree in Microbiology from the University of New Hampshire, and her M.S. and Ph.D. degrees in Pathobiology and Bacteriology (respectively) from the University of Connecticut. Her research focus is on the evolution of virulence, not only to determine how new diseases appear and where they come from but also how to predict what new disease might arise next — pathogen forecasting Follow her on Twitter 1:26 Dr. Matt Bellace has a PhD in clinical psychology with a subspecialty in clinical neuropsychology, the study of the brain and behavior. He was twice awarded the Student Intramural Research and Training Award (IRTA) in neuroscience by the National Institutes of Mental Health to study memory in primates. His clinical training included working with patients at the Comprehensive Epilepsy Center at Thomas Jefferson University Hospital (Philadelphia), treating learning disorders in a pediatric neuropsychology private practice in suburban Philadelphia and performing cognitive behavioral therapy at Drexel University's Student Counseling Center. Matt completed his clinical internship working with traumatic brain and spinal cord injury patients at The Mount Sinai Medical in New York City. In 2005, Matt successfully defended his dissertation, “Activation of the Hippocampus During Emotional Learning,” which was later published in the International Journal of Neuroscience. Check out all things Jon Carroll Follow and Support Pete Coe Pete on YouTube Pete on Twitter Pete On Instagram Pete Personal FB page Stand Up with Pete FB page
Dr. Eric Green is the Director of the National Human Genome Research Institute at the National Institutes of Health. Eric works in the field of genomics. Everything from cars to houses has a blueprint of information that defines its creation and operation. The field of genomics studies DNA, the information molecule of living cells, to understand how living organisms are created and operate. While his research can be time consuming, Eric loves digital photography because of the technological science involved. His two teenagers also keep him busy, and he is a diehard Cardinals baseball fan. He received his B.S. in Bacteriology from the University of Wisconsin, Madison and his M.D. and Ph.D. in Cell Biology from Washington University in St. Louis. Afterward, Eric completed his residency at Washington University in Laboratory Medicine and as part of his residency he did a postdoctoral research in genetics. Eric served on the faculty and as co-investigator in the Human Genome Center at Washington University School of Medicine before accepting a position at the National Institutes of Health where he has been now for over 20 years. Eric has been the recipient of many awards and honors during his career, including the NIH Director's Award (multiple times), the Alumni Achievement and the Distinguished Alumni Awards from Washington University School of Medicine, as well as a Ladue Horton Watkins High School Distinguished Alumni Award. He is also a member of the American Society for Clinical Investigation and the Association of American Physicians. Eric is here with us today to tell us all about his journey through life and science.
Host Jeff Szabo visits SCWA's state-of-the-art water testing laboratory in Hauppauge to follow the typical path of an SCWA water sample. Jeff speaks with top lab staff about their work to keep Suffolk County's water safe, including Director of Water Quality and Laboratory Services Kevin Durk, Laboratory Managers Tom Schneider and Chris Niebling (3:40). Supervisor of Bacteriology & Sample Collection Gavin Marsden discusses how SCWA collects water samples from every community in our service territory (6:00), and the important work of the bacteriology lab (10:10). Assistant Supervising Chemist Amanda Comando tells us how she developed a new way to test for emerging contaminants PFOA & PFOS that was better and faster than the standard EPA method (14:09). Correspondent Seth Wallach hits the streets of Babylon to find out if Suffolk County residents drink their tap water (7:40).
This is one of the most controversial podcasts in the history of The Sacred Speaks; though controversy is familiar territory for the participant, Dr. DAC Hillman. Dr. Hillman began his doctoral research in the middle of a controversy that threatened him with a conflict between the choice of censuring his research to graduate with his doctorate or not pass. So, he did what any self-respecting doctoral student would do - remove the controversial work from his dissertation, and the write a book about it. The Chemical Muse is the book whose central thesis circulates within and through the heart of the “offensive” content – the recreational and sacred use of drugs in classical antiquity. Though his advisors denied that people in classical antiquity used drugs both recreationally and within religious rites, the evidence currently underway confirms his censured thesis. But he did not stop there. Dr. Hillman's research investigates practices by religious Mystery cults in the classic age who participated in the unimaginable, by modern standards. Have you ever imagined that the human body could or would be used as a pharmacy to produce antidotes to drugs and venoms administered to initiates of sacred Mysteries traditions; and that without those human produced antidotes, the initiate's body would begin to fail? What if the bodies of both adults and children were used in such ways? Dr. Hillman and Dr. Price discuss ancient religion, translating ancient texts, hidden language, image, magic, witches, sexual abuse of children, Jesus and St. John, obscured practices within ancient Mystery cults, Magi, the body as pharmacy, Gnostics, heresy, censorship by those in power, homosexuality, the patriarchy, priestesses, myth, & Magic. Bio: Dr. DC Ammon Hillman earned his MS in Bacteriology and Ph.D. in Classics from the University of Wisconsin Madison, where he specialized in Ancient Greek and Roman medicine and pharmacy. His first book, The Chemical Muse, was published with St. Martin's Press immediately after his dissertation committee forced him to delete all references to recreational drugs from his thesis. Dr. Hillman also wrote Original Sin, a work about the use of drug-induced child rape in early Christian ritual. The publication of The Chemical Muse inspired the production of a lengthy History Chanel documentary on the history of drug use in the ancient world. After an official inquiry by the Catholic Church into allegations of demon possession, Dr. Hillman was fired from St. Mary's University of Minnesota. He continues to write about the use of drugs in ancient mystery cults and tutors ancient Greek online. https://www.amazon.com/Chemical-Muse-Roots-Western-Civilization/dp/0312352492 CLASS: http://junghouston.org/program-offering-detail/?id=dfb2b6b6-4eb0-11eb-b993-02dbb43a0b10 Website for The Sacred Speaks: http://www.thesacredspeaks.com WATCH: YouTube for The Sacred Speaks https://www.youtube.com/channel/UCOAuksnpfht1udHWUVEO7Rg Instagram: https://www.instagram.com/thesacredspeaks/ @thesacredspeaks Twitter: https://twitter.com/thesacredspeaks Facebook: https://www.facebook.com/thesacredspeaks/ Brought to you by: https://www.thecenterforhas.com WATCH Get Centered https://www.youtube.com/channel/UCdbeVcDXWXezYMkHJg-2duw Theme music provided by: http://www.modernnationsmusic.com
On today's podcast, I had the honor of talking to E.B. Fred Professor of Natural Sciences Emeritus at UW–Madison and author of the book, Robert Koch--A Life in Medicine and Bacteriology, Thomas Brock, PhD about the titan of microbiology, Robert Koch. In this show, I asked the 93-year-old microbiologist about Koch's life prior to microbiology, his relationship with Louis Pasteur and several of Koch's major contributions to bacteriology from the discovery of the agent of tuberculosis in 1882 to the famous postulates that bear his name.
For three weeks in November, the planet Mercury started moving backwards and alot of people went batsh%t crazy. Jeremy's Iron investigates! Also: Can bacteria talk to each other?? PLUS: Justin B obsesses over horoscopes while Justin Z wonders why he can't sing inside a church and why single people don't get to have singledom ceremonies. It's a water-tight show, really. REFERENCES: Julia C. van Kessel. PQS Signaling for More than a Quorum: the Collective Stress Response Protects Healthy Pseudomonas aeruginosa Populations. Journal of Bacteriology, 2019; 201 (23) DOI: 10.1128/JB.00568-19
Dr. Paul Weimer, Associate Professor of Bacteriology, Emeritus at UW- Madison, shares his experiences working with dairy researchers in South Africa. Bryce Knorr, commodity specialist with Farm Futures magazine, sizes up the market influences going into a holiday abbreviated week. See omnystudio.com/listener for privacy information.
Tracy Carmack is a Certified Clinical Nutritionist (CCN), with a BS in Bacteriology. She is also a Traditional Naturopath, and a Fellow in Blood Type Science. She is trained in Delayed Enhanced Fluoroimmuno Assay Technology (DELFIA) , Hyperion Robotics Systems, and the TECAN Robotic Instruments. Her specialties include forensics, hormone balancing, detoxification, nutrigenomics, and gut health.She is co-founder of Texans For Health Freedom Author of "Voice Tells No Lies" a spectrum of EVOX case studies. Most recently, she co-founded the Microbiome Revolution to bring awareness of glyphosate aerial spraying, GMO, vaccine, and pharmaceutical effects on the human microbiome.MicrobiomeRevolution.org
© 2020-2025 Ivy Podcast Discovery LLC
